Treatment Study for Subjects with Severe Hemophilia A or B

Clinical Trial Title

A multicenter, open-label, multiple ascending dose study to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and efficacy of subcutaneous and/or intravenous PF-06741086 in subjects with severe hemophilia A or B.

Contact Information

Lisa Boggio, MD

Clinical Trial Protocol Description:

Nineteen office clinic visits over 5 months.

Clinical Trial Eligibility Criteria:

In order to participate you must meet the following criteria:

  • Are age 18-64 years old.
  • Have hemophilia A or B.
  • Have had 6 bleeds within 6 months.
  • Have on demand (PRN) factor usage.

This is a partial list of elgibility requirements.

Study Details

Clinical Trial Investigator

Lisa Boggio, MD

Contact Information

Lisa Boggio, MD

(312) 942-3034

Location

Rush University Medical Center

1620 W Harrison St
Chicago, IL 60612

Get Directions

Clinical Trial FAQs

Find out if a clinical trial makes sense for you.

Learn more
Learn more